Subscribe to our Newsletters !!
Few developments in science and technology have be
Worldwide, millions of workers handle chemicals us
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceutica
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Mi
AstraZeneca said on Tuesday it began early stage trials to get an antibody-based treatment for the prevention and treatment of COVID-19, as the British drugmaker also ploughs on with its vaccine candidate.
The trial will assess if AZD7442, a blend of two monoclonal antibodies, is tolerable and safe in up to 48 healthy participants between the ages of 18 and 55 years in the uk together with the backing of the USA.
